PUMA BIOTECHNOLOGY, INC. Quarterly Interest Expense in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Puma Biotechnology, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2018 to Q1 2024.
  • Puma Biotechnology, Inc. Interest Expense for the quarter ending March 31, 2024 was $3.36M, a 1.42% increase year-over-year.
  • Puma Biotechnology, Inc. Interest Expense for the twelve months ending March 31, 2024 was $13.4M, a 9.29% increase year-over-year.
  • Puma Biotechnology, Inc. annual Interest Expense for 2023 was $13.3M, a 15% increase from 2022.
  • Puma Biotechnology, Inc. annual Interest Expense for 2022 was $11.6M, a 9.49% decline from 2021.
  • Puma Biotechnology, Inc. annual Interest Expense for 2021 was $12.8M, a 8.82% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $13.4M $3.36M +$47K +1.42% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $13.3M $3.35M +$75K +2.29% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $13.3M $3.34M +$392K +13.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $12.9M $3.33M +$623K +23.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $12.2M $3.31M +$648K +24.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $11.6M $3.28M +$561K +20.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $11M $2.95M -$174K -5.58% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $11.2M $2.7M -$816K -23.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $12M $2.66M -$786K -22.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $12.8M $2.72M -$849K -23.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $13.7M $3.12M -$506K -14% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $14.2M $3.52M -$266K -7.03% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $14.4M $3.45M +$382K +12.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $14M $3.57M +$491K +16% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-02
Q3 2020 $13.6M $3.63M +$575K +18.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $13M $3.78M -$664K -14.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $13.6M $3.07M -$1.38M -30.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $15M $3.08M -$744K -19.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-03
Q3 2019 $15.8M $3.05M -$447K -12.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $16.2M $4.45M +$1.86M +71.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $14.3M $4.44M +$3.36M +312% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $11M $3.82M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $3.5M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $2.59M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $1.08M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.